avapro has been researched along with Cardiac Diseases in 2 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nako, H | 1 |
Kataoka, K | 1 |
Koibuchi, N | 1 |
Dong, YF | 1 |
Toyama, K | 1 |
Yamamoto, E | 1 |
Yasuda, O | 1 |
Ichijo, H | 1 |
Ogawa, H | 1 |
Kim-Mitsuyama, S | 1 |
Coca, A | 1 |
Giner, V | 1 |
1 review available for avapro and Cardiac Diseases
Article | Year |
---|---|
[Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
Topics: Aged; Angiotensin II; Angiotensin Receptor Antagonists; Anti-Arrhythmia Agents; Antihypertensive Age | 1999 |
1 other study available for avapro and Cardiac Diseases
Article | Year |
---|---|
Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Biphenyl Compounds; Blood Pressure; Blo | 2012 |